BALAXI PHARMACEUTICALS (BALAXI) — Financial Results

📢 Key Event
Corrections filed for XBRL errors in expense figures and comprehensive income signs

🔄 What Changed

Revised standalone Total Expense to INR 2319.29 Lakhs; corrected consolidated Other Comprehensive Income from negative to positive values totaling INR 844.46 Lakhs (Q3) and 1592.31 Lakhs (FY2026); updated Total Comprehensive Income figures

💡 Investor Takeaway
Shareholders should note that financial figures were corrected for accuracy but no operational changes or future performance guidance were provided in this announcement

Balaxi Pharmaceuticals corrected minor errors in its Q3 FY2026 standalone financial XBRL filings, adjusting Employee Benefit Expense to INR 229.66 Lakhs and Total Expense to INR 2319.29 Lakhs, and fixed sign errors in consolidated Other Comprehensive Income that had incorrectly shown negative values, changing Total Comprehensive Income from -783.17 Lakhs to 905.74 Lakhs for Q3 and from -1450.62 Lakhs to 1592.31 Lakhs for the full year. The company also reaffirmed its audited FY2026 results showing total assets of INR 33,702.95 Lakhs, equity of INR 24,907.63 Lakhs, and declared a dividend of INR 0.11 per share following a 1:5 stock split. The auditors issued an unmodified opinion on both standalone and consolidated financial statements, confirming compliance with Ind AS and SEBI regulations, and validated the financials of key international subsidiaries including Balaxi Global FZCO in Dubai, which reported revenue of INR 7,071.37 Lakhs and a net loss of INR 133.13 Lakhs for the quarter ended March 31, 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BALAXI ✨ Ask AI About This

About BALAXI PHARMACEUTICALS LIMITED (BALAXI)

Healthcare · Pharmaceuticals · Listed on NSE

ROE: 1.1% ROCE: 3.6%

View full BALAXI stock details →

📡 Get AI alerts when BALAXI files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BALAXI — Free

💡 Ask AI about this filing

"How does the corrected comprehensive income impact prior quarter comparisons?" "What is the revenue contribution from Balaxi Global FZCO in Dubai?" "When will unaudited results for Balaxi Healthcare Ecuador be finalized?"

Ask AI Free →

📊 More BALAXI filings

See all BALAXI filings →

🔥 Also filed on 14 July 2026

ASHIMASYN Ashima Limited Corporate Action TITAN Titan Company Limited Financial Results FAIRCHEMOR Fairchem Organics Limited Financial Results MANAKCOAT Manaksia Coated Metals & Industries Limited Financial Results MANAKCOAT Manaksia Coated Metals & Industries Limited Corporate Action SAURASHCEM Saurashtra Cement Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BALAXI files new disclosures

Track BALAXI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track BALAXI — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd